Development of Enzymatic-Resistant and Compliant Decellularized Extracellular Matrixes via Aliphatic Chain Modification for Bladder Tissue Engineering
- 10 August 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (33) , 37301-37315
Abstract
Here, we report the design and development of highly stretchable, compliant, and enzymatic-resistant transiently cross-linked decellularized extracellular matrixes (dECMs) (e.g., porcine small intestine submucosa/dSIS, urinary bladder matrix/dUBM, bovine pericardium/dBP, bovine dermis/dBD, and human dermis/dHD). Specifically, these dECMs were modified with long aliphatic chains (C9, C14, and C18). Upon modification, dECMs became significantly resistant to enzymatic degradation for extended periods, showed increased water contact angle (>20%-90%), and stretched >200% than their control counterparts. Modified dECMs are compliant, undergoing 100% elongation at only 0.3-0.5 MPa of applied tensile stress (∼10%-25% of their control counterparts), similar to the control bladder tissue. Furthermore, modified dECMs remain structurally stable at the physiological temperature with increased storage and loss modulus values but decreased tan δ values compared to their control counterparts. Although modification reduces cell adhesion, the gene expressions in polarized macrophages remain unchanged (e.g., TGFβ, CD163, and CD86), except for the modified bovine pericardium (dBP) where a significant decrease in TNFα gene expression is observed. When implanted in the rat subcutaneous model, modified dECMs degraded relatively slowly and did not cause significant fibrotic tissue formation. The numbers of pro-regenerative macrophages increased to several folds in a later time point of evaluation. Modified dECM also supported the bladder wall regeneration with formations of the urothelium, lamina propria, blood vessels, and muscle bundles and reduced the occurrence of calculi formation by 50% in a rat bladder augmentation model. We anticipate that the enhanced stretchability, compliance, and physiological stability of dECMs indicate their suitability for urologic tissue regeneration.Keywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering (R21EB026711)
- Johns Hopkins Greenberg Bladder Cancer Award
This publication has 65 references indexed in Scilit:
- Bladder tissue regeneration using acellular bi-layer silk scaffolds in a large animal model of augmentation cystoplastyBiomaterials, 2013
- The Size of the Unbranched Aliphatic Chain Determines the Immunomodulatory Potency of Short and Long Chain n-AlkanolsJournal of Biological Chemistry, 2013
- Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1Proceedings of the National Academy of Sciences of the United States of America, 2012
- Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materialsActa Biomaterialia, 2012
- Early Stages of In Situ Bladder Regeneration in a Rodent ModelTissue Engineering Part A, 2010
- The Impact of Contact Angle on the Biocompatibility of BiomaterialsOptometry and Vision Science, 2010
- The bladder extracellular matrix. Part I: architecture, development and diseaseNature Reviews Urology, 2009
- Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular componentBiomaterials, 2009
- Foreign body reaction to biomaterialsSeminars in Immunology, 2008
- Immune response to biologic scaffold materialsSeminars in Immunology, 2008